Taken together, to date, most circRNAs affecting the response to endocrine therapies have been reported to affect tamoxifen sensitivity of BC cells by sponging up miRNAs targeting ERα coregulators or genes modulating ESR1 expression. The gene discussed is ESR1; the disease is breast cancer.